Oppenheimer Downgrades ARYx Therapeutics (ARYX) to Perform

February 22, 2010 7:54 AM EST
Get Alerts ARYX Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 4 | Down: 17 | New: 8
Join SI Premium – FREE
Oppenheimer downgrades ARYx Therapeutics (Nasdaq: ARYX) from Outperform to Perform.

To see all the upgrades/downgrades on shares of ARYX, visit our Analyst Ratings page.

ARYx Therapeutics, Inc. (ARYx) is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates.

You May Also Be Interested In

Related Categories